Covid 19

Use this section to provide a description of your blog.

Philips details plans to increase its hospital ventilator production

Posted by CPAP Indo on

Philips details plans to increase its hospital ventilator production to 4,000 units/week by Q3 2020, and introduces its new Philips Respironics E30 ventilator with an immediate production of 15,000 units/week

  • Philips engages manufacturing partners Flex Ltd. (NASDAQ: FLEX) and Jabil (NYSE: JBL), as well as other partners, to further expand its hospital ventilator assembly lines and strengthen its supply chain
  • Company introduces the Philips Respironics E30 ventilator, a versatile and easy-to-use ventilator to treat patients with respiratory insufficiency, designed for large scale production
  • FDA authorized the Philips Respironics E30 ventilator for use in the US during the COVID-19 public health emergency through its EUA process on April 8, 2020; Philips is working with the relevant regulatory authorities to also distribute the device globally
  • Philips continues to work with its global suppliers to ensure a sufficient and uninterrupted supply of components. This is the rate-limiting step, and requires the support of all countries involved
 Amsterdam, the Netherlands  Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today provided an update on its plans to double the production of its hospital ventilators by May 2020 and achieve a four-fold increase by the third quarter of 2020. This plan builds on Philips’ initial production increase in the first three months of the year, which already enabled the supply of additional ventilators – that are critical for the treatment of COVID-19 patients – to hospitals in the most affected regions in China, southern Europe and the US. To further address the huge global demand, Philips introduced its new Philips Respironics E30 ventilator, a versatile and easy-to-use non-invasive and invasive ventilator, which has been designed for large scale production. 
CONTINUE READING.......

Read more

Philips details plans to increase its hospital ventilator production to 4,000 units/week by Q3 2020, and introduces its new Philips Respironics E30 ventilator with an immediate production of 15,000 units/week

  • Philips engages manufacturing partners Flex Ltd. (NASDAQ: FLEX) and Jabil (NYSE: JBL), as well as other partners, to further expand its hospital ventilator assembly lines and strengthen its supply chain
  • Company introduces the Philips Respironics E30 ventilator, a versatile and easy-to-use ventilator to treat patients with respiratory insufficiency, designed for large scale production
  • FDA authorized the Philips Respironics E30 ventilator for use in the US during the COVID-19 public health emergency through its EUA process on April 8, 2020; Philips is working with the relevant regulatory authorities to also distribute the device globally
  • Philips continues to work with its global suppliers to ensure a sufficient and uninterrupted supply of components. This is the rate-limiting step, and requires the support of all countries involved
 Amsterdam, the Netherlands  Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today provided an update on its plans to double the production of its hospital ventilators by May 2020 and achieve a four-fold increase by the third quarter of 2020. This plan builds on Philips’ initial production increase in the first three months of the year, which already enabled the supply of additional ventilators – that are critical for the treatment of COVID-19 patients – to hospitals in the most affected regions in China, southern Europe and the US. To further address the huge global demand, Philips introduced its new Philips Respironics E30 ventilator, a versatile and easy-to-use non-invasive and invasive ventilator, which has been designed for large scale production. 
CONTINUE READING.......

Read more


Philips debuts smaller emergency ventilator amid manufacturing expansion

Posted by CPAP Indo on

Philips is rolling out a new emergency-use ventilator to help relieve some of the burden on intensive care units as well as to provide care both inside and outside of hospitals.

Built as a smaller alternative to the more durable, full-featured hospital ventilators currently in high demand, the Respironics E30 device can deliver high-flow oxygen both invasively and noninvasively and can include air filters to help minimize healthcare workers’ potential exposure to the coronavirus.

Designed for mass production, Philips said it plans to quickly scale up manufacturing, with a goal of producing 15,000 units per week by the end of the month. It’s described by the FDA as a portable device and capable of being used in converted spaces for large numbers of COVID-19 patients such as convention centers, university dorms or hotels.   CONTINUE READING.......

Read more

Philips is rolling out a new emergency-use ventilator to help relieve some of the burden on intensive care units as well as to provide care both inside and outside of hospitals.

Built as a smaller alternative to the more durable, full-featured hospital ventilators currently in high demand, the Respironics E30 device can deliver high-flow oxygen both invasively and noninvasively and can include air filters to help minimize healthcare workers’ potential exposure to the coronavirus.

Designed for mass production, Philips said it plans to quickly scale up manufacturing, with a goal of producing 15,000 units per week by the end of the month. It’s described by the FDA as a portable device and capable of being used in converted spaces for large numbers of COVID-19 patients such as convention centers, university dorms or hotels.   CONTINUE READING.......

Read more